Inventor · Slough, GB

Christopher James Lock

13Patents
4h-index
28Co-inventors
60Inventor score

Filing activity: May 30, 1997 → Mar 19, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8399483B2 Quinoxaline and quinoline derivatives as kinase inhibitors Chemistry; Metallurgy 51 Active
US5786484A Racemization and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof Chemistry; Metallurgy 37 Expired
US8765762B2 Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome Chemistry; Metallurgy 8 Active
US9079909B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome Physics 5 Active
US9371332B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome Chemistry; Metallurgy 3 Active
US9260381B2 Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome Physics 3 Active
US9227976B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Chemistry; Metallurgy 3 Active
US9783545B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Chemistry; Metallurgy 2 Active
US9549910B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Physics 2 Active
US10130619B2 Amido thiadiazole derivatives as NADPH oxidase inhibitors Chemistry; Metallurgy 1 Active
US10307422B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Physics 0 Active
US9925187B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Physics 0 Active
US8653272B2 Fused pyridine derivatives as kinase inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.